Irrfan Khan tweeted 2 months later, treatment of Neuro Endocrine tumors in Dubai
Fans are waiting a lot about Irrfan Khan's health updates to treat Neuro Endocrine tumors in Dubai, so Irrfan has expressed interest in tweeting his forthcoming film.

New Delhi: Bollywood actor Irfan Khan is currently treating his illness in London. In such a situation, the fans are eagerly awaiting their health updates. About two months ago Irrfan Khan tweeted that he had neuroendocrine tumors, which he is treating abroad. Two months later, Irfan has again made a tweet with his tweet handle. However, in this tweet he has not updated his illness or health.
Irrfan's tweet shows that he is very curious about his films and is also feeling regret that he is not currently able to join the promotions and related activities of his films. Talking about Irrfan's latest tweet, he has shared his upcoming movie 'Caravan' with Poster Fans.
Tipping this poster, Irrfan wrote, "The experience of innocence of the beginning can not be bought, thanks to Dilar and Mithila joining the caravan, two caravans are running, one and the other movie." Khurana's film Caravan is a comedy movie, which is being released on August 10, in which different characters come together in one place with their own jarni.
The film starring Dilshan Salman, Kristi Kharbanda and Mithila Parkar are also working in the film for the first time with Irrfan, son of South Star Mammootty. Irfan left for London around March 20. Recently, Dilcar, who was seen with Irrfan in the film, shared the film with the poster fans. It is clear that Irfan is very excited about this movie.
Earlier, Irfan was unable to promote his film 'Blackmail'. On March 19, a photo has been shared with Irrfan Khan's Instagram account. Irfan is not visible in this picture but his shadow is visible. Sharing this picture has written very positive and beautiful things. Irrfan wrote, "God we talk about most he has created us, in silent darkness he walks with us silently". These are words that we always hear.

No comments:
Post a Comment